home-insights

Insights

The 21st Century Cures Act: Implications for Human Subject Protections

Authors: Daniel Borasky, MPH, CIP Vice President of Quality Management Copernicus Group IRB, a WIRB-Copernicus Group Company David Forster…

Continue Reading

Infectious Disease Challenge Studies: Ethical Issues in Causing Disease for Medical Knowledge

Authors: Daniel Kavanagh, PhD Senior Director, Biosafety & Gene Therapy WIRB-Copernicus Group Currien MacDonald, MD, CIP Board Chair…

Continue Reading

Reducing Study Team and Site Burden through an Integrated eClinical Platform Solution

Author: Lance Converse Chief Innovation Officer WIRB-Copernicus…

Continue Reading

VIEW MORE >

home-news

News

To What Extent Do Risks Need to Be Minimized?

Authors: Jeffrey Cooper, MD, MMM Vice President, Process & Strategic Improvement WIRB-Copernicus Group (WCG) Lindsay McNair, MD, MPH,…

Continue Reading

Data-driven Site Selection: Accelerating Your Trials Through Predictive Site Modeling

Author: Suzanne Caruso VP, Clinical Solutions WIRB-Copernicus Group…

Continue Reading

Sites rate their relationships with IRBs

WCG’s Chief Growth Officer and Executive Vice President, Nicholas Slack, MBE, is featured in the recent article, “Sites rate their relationships…

Continue Reading

VIEW MORE >

home-events

Events

SCOPE Summit for Clinical Ops Executives – January 24-26, 2017

Date Conference Location January 24-26, 2017 SCOPE Summit for Clinical Ops Executives For more information, please click…

Continue Reading

Public Responsibility in Medicine and Research (PRIM&R) 2016 AER Conference – November 13-16, 2016

Date Conference Location November 13-16, 2016 Public Responsibility in Medicine and Research (PRIM&R) 2016 AER Conference For more…

Continue Reading

American Biological Safety Association (ABSA) 59th Annual Conference – September 30-October 5, 2016

Date Conference Location September 30th-October 5th American Biological Safety Association (ABSA) 59th Annual Conference Grapevine,…

Continue Reading

VIEW MORE >

Print Friendly